Autolus Therapeutics PLC (AUTL)

NASDAQ: AUTL · IEX Real-Time Price · USD
3.34
-0.25 (-6.96%)
Aug 19, 2022 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 202120202019201820172016
Revenue
2.331.722.911.411.691.21
Revenue Growth (YoY)
35.86%-41.02%106.68%-16.89%39.69%-
Gross Profit
2.331.722.911.411.691.21
Selling, General & Admin
31.8734.9739.4522.799.15.15
Research & Development
134.79134.89105.4236.1516.0110.44
Other Operating Expenses
0.6804.1000
Operating Expenses
167.33169.86148.9758.9425.1115.59
Operating Income
-165-168.15-146.06-57.53-23.42-14.38
Interest Expense / Income
1.1100000
Other Expense / Income
-0.12-1.89-7.06-5.5-0.04-0.05
Pretax Income
-165.99-166.26-139.01-52.03-23.38-14.33
Income Tax
-23.89-24.16-15.16-7.28-3.65-1.78
Net Income
-142.1-142.09-123.85-44.75-19.73-12.55
Net Income Common
-142.1-142.09-123.85-44.75-19.73-12.55
Shares Outstanding (Basic)
725243321410
Shares Outstanding (Diluted)
725243321410
Shares Change
39.81%19.72%36.47%128.95%38.76%-
EPS (Basic)
-1.97-2.76-2.88-1.42-1.43-1.26
EPS (Diluted)
-1.97-2.76-2.88-1.42-1.43-1.26
Free Cash Flow Per Share
-1.76-2.57-2.78-1.29-1.40-1.18
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-7081.50%-9804.40%-5022.80%-4089.10%-1383.20%-1186.10%
Profit Margin
-6098.50%-8285.40%-4258.90%-3180.60%-1165.20%-1035.50%
Free Cash Flow Margin
-5438.50%-7722.40%-4120.50%-2889.60%-1136.20%-965.70%
Effective Tax Rate
14.39%14.53%10.91%13.99%15.62%12.40%
EBITDA
-156.43-160.6-134.4-50.32-22.37-13.85
EBITDA Margin
-6713.50%-9364.40%-4621.60%-3576.50%-1321.40%-1142.70%
Depreciation & Amortization
8.465.664.611.711.010.48
EBIT
-164.88-166.26-139.01-52.03-23.38-14.33
EBIT Margin
-7076.50%-9694.30%-4780.20%-3698.00%-1381.00%-1182.10%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).